Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study.
Laurence H BakerPhilip S BoonstraDenise K ReinkeErin J Peregrine AntalisBradley J ZebrackRichard L Weinberg
Published in: Journal of cancer metastasis and treatment (2020)
The results of this pilot study support the presence of modifiable CAD risk factors in this population of sarcoma survivors. Evidence-based guidelines for high-risk survivors of rare cancers are needed.